22-26466246-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_022081.6(HPS4):āc.686A>Gā(p.Glu229Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.871 in 1,613,862 control chromosomes in the GnomAD database, including 616,234 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_022081.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPS4 | NM_022081.6 | c.686A>G | p.Glu229Gly | missense_variant | 9/14 | ENST00000398145.7 | NP_071364.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS4 | ENST00000398145.7 | c.686A>G | p.Glu229Gly | missense_variant | 9/14 | 1 | NM_022081.6 | ENSP00000381213.2 |
Frequencies
GnomAD3 genomes AF: 0.821 AC: 124833AN: 152074Hom.: 51952 Cov.: 32
GnomAD3 exomes AF: 0.844 AC: 212237AN: 251394Hom.: 90824 AF XY: 0.857 AC XY: 116494AN XY: 135876
GnomAD4 exome AF: 0.877 AC: 1281410AN: 1461670Hom.: 564275 Cov.: 52 AF XY: 0.880 AC XY: 639631AN XY: 727146
GnomAD4 genome AF: 0.821 AC: 124889AN: 152192Hom.: 51959 Cov.: 32 AF XY: 0.822 AC XY: 61178AN XY: 74418
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Glu229Gly in exon 9 of HPS4: This variant is not expected to have clinical signi ficance because it has been identified in 31.1% (1372/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs713998). - |
Hermansky-Pudlak syndrome 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Hermansky-Pudlak syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at